Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
GLORIA GONZÁLEZ ASEGUINOLAZA
DEPUTY DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
Scientific production in data
During the year 2021 the scientific activity of Cima recorded a total of 261 scientific publications.
261
scientific publications in total
211
scientific publications
in the first quartile
11,80
average impact factor
with authorship
Our research results in high impact journals
Outstanding scientific publications
|
Attal, M. et al. Lancet. 2019 Dec 7;394(10214):2096-2107. |
|
|
| Perez- Ruiz, E. et al. Nature. 2019 May;569(7756):428-432. Immunology and Immunotherapy Program Impact factor: 42.778
|
|
|
| Benechet, AP. et al. Nature 2019. Oct;574(7777):200-205. Gene Therapy and Regulation of Gene Expression Program Impact factor: 42.778
|
| Richardson, PG. et al. Lancet Oncology 2019. Jun;20(6):781-794 Hemato-oncology Program Impact factor: 33.752
|
|
|
| Segovia, C. et al. Nature Medicine 2019. Jul;25(7):1073- 1081. Hemato-oncology Program Impact factor: 36.130
|
|
|
| Melero I et al. Nature Medicine 2019. Mar;25(3):470-476. Immunology and Immunotherapy Program Impact factor: 36.130
|
|
|
| Swarup, V. et al. Nature Medicine 2019. Jan;25(1):152-164. Neuroscience Program Impact factor: 36.130
|
| Kim, JW. et al. Nature Medicine 2019. Nov;25(11):1783- 1795. Collaboration Dr. Vicent Solid Tumor Program Impact factor: 36.130
|
|
|
| Berraondo, P. et al. Cancer Discovery 2019. Aug;9(8):1003- 1005 Editorial Material. Immunology and Immunotherapy Program Impact factor: 29.497
|
|
|
| Etxeberria, I. et al. Cancer Cell 2019. Dec 9;36(6):613-629.e7 Immunology and Immunotherapy Program Impact factor: 26.602
|
|
|
| Rodriguez-Ruiz, ME. et al. Nature Immunology. Doi: 10.1038/ s41590-019-0561-4. Epub 2019 Dec 23. Immunology and Immunotherapy Program Impact factor: 20.479 |
|
|
|
Mastellos, et al. Nature Immunology 2019 Nov;20(11):1556. Editorial Material.
|
| Díez J et al. European Heart Journal 2019. Mar 21;40(12):979-981 Editorial Material. Cardiovascular Disease Program Impact factor: 22.673 |
|
|
| Ravassa, S. et al. Journal of the American College of Cardiology 2019. Apr 2;73(12):1398-1410 Cardiovascular Disease Program Impact factor: 20.589 |
| Berraondo, P. et al. Gut. 2019 Jul;68(7):1323-133 Immunology and Immunotherapy Program Impact factor: 19.819 |
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- Expression of p53 protein isoforms predicts survival in patients with multiple myeloma Jun 1, 2022 | Magazine: American Journal of Hematology
- ASTCT Clinical Practice recommendations for transplant and cellular therapies in multiple myeloma Jun 1, 2022 | Magazine: Transplantation and Cellular Therapy
- New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming May 26, 2022 | Magazine: Journal of Experimental & Clinical Cancer Research
- Revisiting intracavitary immunotherapy of cancer May 13, 2022 | Magazine: Clinical Cancer Research